carvedilol (Q412534)

carvedilol (English)

19 November 2016

COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O

1 reference

carvedilol (English)

19 November 2016

37.5 milligram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=C07AG02

1 reference

14 February 2018

World Health Organisation international non-proprietary name

carvedilol (English)

1 reference

carvedilol (English)

medical condition treated

3 October 2016

arterial hypertension

2 references

13 December 2016

2 October 2018

congestive heart failure

2 references

13 December 2016

2 October 2018

myocardial infarction

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

2 October 2018

atrial fibrillation

1 reference

United States Food and Drug Administration

2 October 2018

arterial hypertension

start time

14 September 1995

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/0K47UL67F2

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020297s029lbl.pdf

myocardial infarction

start time

14 September 1995

approved by

United States Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/0K47UL67F2

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020297s029lbl.pdf

congestive heart failure

start time

14 September 1995

approved by

United States Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/0K47UL67F2

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020297s029lbl.pdf

tachycardia

0 references

significant drug interaction

verapamil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

verapamil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

digoxin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rivastigmine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methyldopa

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

terazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

prazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

doxazosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tamsulosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfuzosin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diltiazem

myocardial depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sinoatrial arrest

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atrioventricular block

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxonidine

withdrawal hypertension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

decreased heart rate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

shortened atrioventricular conduction time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atrioventricular block

1 reference

A reference set of clinically relevant adverse drug-drug interactions

digoxin

third-degree atrioventricular block

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

1 reference

17 August 2016

1 reference

17 August 2016

1 reference

LiverTox likelihood score

17 August 2016

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Carvedilol

last update

15 January 2017

mass

406.189257 dalton

1 reference

carvedilol (English)

3 October 2016

1 reference

5 March 2018

antihypertensive drug

1 reference

15 March 2018

1 reference

15 March 2018

1 reference

MeSH descriptor ID

C043211

adrenergic alpha-1 receptor antagonists

15 March 2018

1 reference

InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3

15 March 2018

Carvedilol

0 references

Identifiers

InChI

1 reference

carvedilol (English)

19 November 2016

2 references

carvedilol (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

72956-09-3

2 references

carvedilol (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=72956-09-3

10 April 2021

1 reference

Carvedilol (English)

19 November 2016

2 references

carvedilol (English)

19 November 2016

Reaxys registry number

1514452

1 reference

carvedilol (English)

3 October 2016

mapping relation type

2 references

CARVEDILOL (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3

1 reference

CARVEDILOL (English)

19 November 2016

2 references

inferred from InChIKey

10082334

2 references

based on heuristic

inferred from InChIKey

splash10-0a4i-1662900000-f901a62f255da92e9a09

1 reference

0 references

RTECS number

UA8670000

1 reference

imported from Wikimedia project

1 reference

Hazardous Substances Data Bank

28 October 2019

CARVEDILOL (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.117.236

27 December 2018

ECHA Substance Infocard ID

[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine (English)

quotation

CAS no.: 72956-09-3 (English)

100.117.236

1 reference

http://echa.europa.eu/de/information-on-chemicals/registered-substances

1 reference

Carvedilol (English)

publication date

17 November 2015

1 reference

carvedilol (English)

19 November 2016

Carvedilol

0 references

0 references

0 references

0 references

D03.633.100.473.144.125

0 references

0 references

1 reference

carvedilol (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0015267

2 references

based on heuristic

inferred from InChIKey

2 references

carvedilol (English)

19 November 2016

MedlinePlus drug identifier

a697042

0 references

PatientsLikeMe treatment ID

0 references

1 reference

carvedilol (English)

19 November 2016

0 references

1 reference

1 reference

carvedilol (English)

3 October 2016

1 reference

carvedilol (English)

Brockhaus Enzyklopädie online ID

3 October 2016

carvedilol

0 references

DeCS ID

57565

0 references

electronic Essential Medicines List medicine ID

0 references

1 reference

28 October 2013

Microsoft Academic ID (discontinued)

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI

C0054836

1 reference

carvedilol (English)

19 November 2016

0 references

0 references

WordNet 3.1 Synset ID

02976854-n

1 reference